PRAX — Praxis Precision Medicines Inc · $7.38B cap

Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.

Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.

Use this PRAX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PRAX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PRAX SEC filings page. Lician reads the product cache first so this HTML stays unique to Praxis Precision Medicines Inc even when a live quote feed is slow.

Praxis Precision Medicines Inc latest statements (FY2025)

Latest cached year on this hub. Full PRAX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$303.3M
  • Total Assets$937.9M
  • Total Debt$0
  • Free Cash Flow-$249.1M

PRAX recent filings